Evidence map›Paper›PMID 22967068›Full record

ArticleOrganic letters2012

New WS9326A congeners from Streptomyces sp. 9078 inhibiting Brugia malayi asparaginyl-tRNA synthetase.

Zhiguo Yu, Sanja Vodanovic-Jankovic, Michael Kron, Ben Shen

Abstract read
In one paragraph

Article in Organic letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Aminoacyl-tRNA synthetases as therapeutic targets.Nature reviews. Drug discovery · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites.International journal for parasitology. Drugs and drug resistance · 2014
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhiguo YuDepartment of Chemistry, the Scripps Research Institute, Jupiter, Florida 33458, USA.
Sanja Vodanovic-Jankovic
Michael Kron
Ben Shen

Funding

Natural Products from Under-explored MicroorganismsP41GM086184 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI SHEN, BEN · 2010 to 2012
$1.1M
NIGMS NIH HHS GM086184NIGMS NIH HHS P41 GM086184PHS HHS A1053877
6 · The paper itself

Abstract

Lymphatic filariasis is caused by the Brugia malayi parasite. Three new congeners of the depsipeptide WS9326A (1), WS9326C (2), WS9326D (3), and WS9326E (4), were isolated from Streptomyces sp. 9078 by using a B. malayi asparaginyl-tRNA synthetase (BmAsnRS) inhibition assay. WS9326D specifically inhibits the BmAsnRS, kills the adult B. malayi parasite, and does not exhibit significant general cytotoxicity to human hepatic cells, representing a new lead scaffold for antifilarial drug discovery.

Indexed as

LactonesPeptides, CyclicAnimalsAspartate-tRNA LigaseBrugia malayiDepsipeptidesFilariasisHepatocytesHumansMolecular StructureRNA, Transfer, Amino AcylStereoisomerismStreptomycesasparaginyl-tRNA synthetaseAspartate-tRNA LigaseDepsipeptidesLactonesPeptides, CyclicRNA, Transfer, Amino AcylWS 9326A

Identifiers

PMID22967068
PMCPMC3460372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.